https://www.selleckchem.com/pr....oducts/santacruzamat
003), oral **** (P value=0.02) were found to be associated with HSV-2 acquisition in HIV patients. All other risk factors such as history of transactional ****, age at ****ual debut and condom use were not significant. The results highlight the potential public health impact of HSV-2 particularly in a developing country like Nigeria where HSV-2 testing is not included in our testing and treatment protocol for HIV. This result should lead to commencement of HSV type-specific serological testing in the HIV infected populati
Gusto
Magkomento
Ibahagi
